Q3 2024 EPS Estimates for Ontrak, Inc. Reduced by Analyst (NASDAQ:OTRK)

Ontrak, Inc. (NASDAQ:OTRK) – Research analysts at Roth Capital dropped their Q3 2024 earnings per share (EPS) estimates for Ontrak in a report issued on Thursday, October 10th. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings of ($1.56) per share for the quarter, down from their prior forecast of ($1.50). The consensus estimate for Ontrak’s current full-year earnings is ($7.35) per share. Roth Capital also issued estimates for Ontrak’s Q4 2024 earnings at ($1.41) EPS, FY2024 earnings at ($7.39) EPS, FY2025 earnings at ($3.67) EPS, FY2026 earnings at ($0.36) EPS, FY2027 earnings at $0.06 EPS and FY2028 earnings at $0.10 EPS.

Ontrak (NASDAQ:OTRK) last posted its quarterly earnings results on Thursday, August 8th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.09). Ontrak had a negative net margin of 222.54% and a negative return on equity of 238.43%. The company had revenue of $2.45 million during the quarter, compared to the consensus estimate of $2.60 million. During the same period in the prior year, the company posted ($1.84) EPS.

Separately, Roth Mkm dropped their price objective on Ontrak from $4.00 to $3.00 and set a “buy” rating for the company in a report on Friday, August 9th.

Ontrak Stock Up 3.7 %

Ontrak stock opened at $2.53 on Monday. The firm has a fifty day moving average price of $0.93 and a two-hundred day moving average price of $0.50. The firm has a market cap of $121.36 million, a price-to-earnings ratio of -0.63 and a beta of 2.56. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.64 and a quick ratio of 3.64. Ontrak has a fifty-two week low of $1.81 and a fifty-two week high of $21.29.

Ontrak Company Profile

Ontrak, Inc operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need.